CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024.

IF 3.1 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Intervention and Therapeutics Pub Date : 2024-09-20 DOI:10.1007/s12928-024-01036-y

Yukio Ozaki, Akihiro Tobe, Yoshinobu Onuma, Yoshio Kobayashi, Tetsuya Amano, Takashi Muramatsu, Hideki Ishii, Kyohei Yamaji, Shun Kohsaka, Tevfik F Ismail, Shiro Uemura, Yutaka Hikichi, Kenichi Tsujita, Junya Ako, Yoshihiro Morino, Yuichiro Maekawa, Toshiro Shinke, Junya Shite, Yasumi Igarashi, Yoshihisa Nakagawa, Nobuo Shiode, Atsunori Okamura, Takayuki Ogawa, Yoshisato Shibata, Takafumi Tsuji, Kentaro Hayashida, Junji Yajima, Teruyasu Sugano, Hiroyuki Okura, Hideki Okayama, Katsuhiro Kawaguchi, Kan Zen, Saeko Takahashi, Toshihiro Tamura, Kazuhiko Nakazato, Junichi Yamaguchi, Osamu Iida, Reina Ozaki, Fuminobu Yoshimachi, Masaharu Ishihara, Toyoaki Murohara, Takafumi Ueno, Hiroyoshi Yokoi, Masato Nakamura, Yuji Ikari, Patrick W Serruys, Ken Kozuma

{"title":"CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024.","authors":"Yukio Ozaki, Akihiro Tobe, Yoshinobu Onuma, Yoshio Kobayashi, Tetsuya Amano, Takashi Muramatsu, Hideki Ishii, Kyohei Yamaji, Shun Kohsaka, Tevfik F Ismail, Shiro Uemura, Yutaka Hikichi, Kenichi Tsujita, Junya Ako, Yoshihiro Morino, Yuichiro Maekawa, Toshiro Shinke, Junya Shite, Yasumi Igarashi, Yoshihisa Nakagawa, Nobuo Shiode, Atsunori Okamura, Takayuki Ogawa, Yoshisato Shibata, Takafumi Tsuji, Kentaro Hayashida, Junji Yajima, Teruyasu Sugano, Hiroyuki Okura, Hideki Okayama, Katsuhiro Kawaguchi, Kan Zen, Saeko Takahashi, Toshihiro Tamura, Kazuhiko Nakazato, Junichi Yamaguchi, Osamu Iida, Reina Ozaki, Fuminobu Yoshimachi, Masaharu Ishihara, Toyoaki Murohara, Takafumi Ueno, Hiroyoshi Yokoi, Masato Nakamura, Yuji Ikari, Patrick W Serruys, Ken Kozuma","doi":"10.1007/s12928-024-01036-y","DOIUrl":null,"url":null,"abstract":"<p><p>Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022. Recently, the European Society of Cardiology (ESC) published the guidelines for the management of acute coronary syndrome in 2023. Major new updates in the 2023 ESC guideline include: (1) intravascular imaging should be considered to guide PCI (Class IIa); (2) timing of complete revascularization; (3) antiplatelet therapy in patient with high-bleeding risk. Reflecting rapid advances in the field, the Task Force on Primary PCI of the CVIT group has now proposed an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2024 version.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Intervention and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12928-024-01036-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022. Recently, the European Society of Cardiology (ESC) published the guidelines for the management of acute coronary syndrome in 2023. Major new updates in the 2023 ESC guideline include: (1) intravascular imaging should be considered to guide PCI (Class IIa); (2) timing of complete revascularization; (3) antiplatelet therapy in patient with high-bleeding risk. Reflecting rapid advances in the field, the Task Force on Primary PCI of the CVIT group has now proposed an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2024 version.

查看原文本刊更多论文

经皮冠状动脉介入治疗（PCI）大大降低了 ST 段抬高型心肌梗死（STEMI）患者的死亡率，即使是在心源性休克的情况下。日本心血管介入与治疗协会（CVIT）初级 PCI 工作组于 2018 年提出了急性心肌梗死（AMI）管理的专家共识文件，重点关注初级 PCI 的程序方面，并于 2022 年进行了更新。最近，欧洲心脏病学会（ESC）发布了 2023 年急性冠脉综合征管理指南。2023 年 ESC 指南的主要更新内容包括(1）血管内成像应考虑用于指导 PCI（IIa 级）；（2）完全血管再通的时机；（3）高出血风险患者的抗血小板治疗。为反映该领域的快速发展，CVIT 小组的初级 PCI 特别工作组现已提出更新的 ACS 管理专家共识文件（2024 年版），重点关注初级 PCI 的程序方面。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardiovascular Intervention and Therapeutics CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

6.30

自引率

12.50%

发文量

期刊介绍： Cardiovascular Intervention and Therapeutics (CVIT) is an international journal covering the field of cardiovascular disease and includes cardiac (coronary and noncoronary) and peripheral interventions and therapeutics. Articles are subject to peer review and complete editorial evaluation prior to any decision regarding acceptability. CVIT is an official journal of The Japanese Association of Cardiovascular Intervention and Therapeutics.

文献相关原料

公司名称	产品信息	采购帮参考价格